A study on immune-related adverse events in early phase clinical trials
Not Applicable
Recruiting
- Conditions
- cancer
- Registration Number
- JPRN-UMIN000049431
- Lead Sponsor
- national cancer center hospital
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Recruiting
- Sex
- All
- Target Recruitment
- 800
Inclusion Criteria
Not provided
Exclusion Criteria
none
Study & Design
- Study Type
- Observational
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method To verify the usefulness and validity of comprehensive analysis of cytokines, immune cells, etc. in early clinical trials.
- Secondary Outcome Measures
Name Time Method